Treatment of migraine with aura: comments and perspectives

被引：8
|
作者：
D'Andrea, G
Bonavita, V
Rigamonti, A
Bussone, G
机构：
[1] Ist Nazl Neurol Carlo Besta, I-20133 Milan, Italy
[2] Este Hosp, Ctr Headache & Comorbidities, Monselice, PD, Italy
[3] Univ Naples 2, Inst Neurol Sci, Naples, Italy
来源：
NEUROLOGICAL SCIENCES | 2003年 / 23卷 / 06期
关键词：
migraine; aura; therapy;
D O I：
10.1007/s100720300001
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Migraine with aura (MwA) is a primary headache that affects about 30% of migraine sufferers. The main questions for the physician caring for the patient who has MwA are: when to use preventive medications, what medications to use in acute and preventive treatment, and whether the aura should be treated. The aim of this paper is to review the various therapeutic options for MwA proposed in the current literature and to evaluate their efficacy.
引用
收藏
页码：271 / 278
页数：8
相关论文
共 50 条
  • [31] Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs
    Jakob Møller Hansen
    Andrew Charles
    [J]. The Journal of Headache and Pain, 2019, 20
  • [32] MIGRAINE WITH AURA AND MIGRAINE WITHOUT AURA - AN EPIDEMIOLOGIC-STUDY
    RASMUSSEN, BK
    OLESEN, J
    [J]. CEPHALALGIA, 1992, 12 (04) : 221 - 228
  • [33] MIGRAINE WITH AURA AND MIGRAINE WITHOUT AURA ARE 2 DIFFERENT ENTITIES
    RASMUSSEN, BK
    [J]. CEPHALALGIA, 1995, 15 (03) : 183 - 186
  • [34] Lamotrigine attenuates migraine aura and reduces migraine attacks in patients with migraine with aura
    Lampl, C
    Katsarava, Z
    Limmroth, V
    [J]. NEUROLOGY, 2005, 64 (06) : A401 - A401
  • [35] Depression, migraine with aura and migraine without aura: their familiality and interrelatedness
    Ball, H. A.
    Samaan, Z.
    Brewster, S.
    Craddock, N.
    Gill, M.
    Korszun, A.
    Maier, W.
    Middleton, L.
    Mors, O.
    Owen, M. J.
    Perry, J.
    Preisig, M.
    Rice, J.
    Rietschel, M.
    Jones, L.
    Jones, I.
    Farmer, A. E.
    McGuffin, P.
    [J]. CEPHALALGIA, 2009, 29 (08) : 848 - 854
  • [36] Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs
    Hansen, Jakob Moller
    Charles, Andrew
    [J]. JOURNAL OF HEADACHE AND PAIN, 2019, 20 (01):
  • [37] Successful treatment of persistent migraine aura with divalproex sodium
    Rothrock, JF
    [J]. NEUROLOGY, 1997, 48 (01) : 261 - 262
  • [38] Efficacy of erenumab for the treatment of patients with chronic migraine and aura
    Ashina, Messoud
    Dodick, David
    Goadsby, Peter J.
    Kudrow, David
    Reuter, Uwe
    Tepper, Stewart J.
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert A.
    Mikol, Daniel D.
    [J]. CEPHALALGIA, 2017, 37 : 34 - 35
  • [39] Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: A randomized, double blind, placebo controlled study
    Bigal, ME
    Bordini, CA
    Tepper, SJ
    Speciali, JG
    [J]. HEADACHE, 2002, 42 (09): : 862 - 871
  • [40] Migraine with aura from pathophysiology to treatment: therapeutic strategies
    D'Andrea, G
    Allais, G
    Grazzi, L
    Fumagalli, L
    [J]. NEUROLOGICAL SCIENCES, 2005, 26 (Suppl 2) : S104 - S107
12345